Private Ab TomEqt is 10% Owner at DiaMedica Therapeutics Inc. (DMAC). They have made 1 open-market trade across 1 company since 2023, most recently 2023-06-23.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10.0M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DMAC | 4,326,435 | $32.9M |
Shares reported on the most recent Form 4, priced at the 2023-06-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DMAC | BUY | 2023-06-23 | 2023-06-27 | $3.40 | $10.0M | -15.1% | -25.1% | -41.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.